Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
Rheumatoid Arthritis
•
Methotrexate
•
General Rheumatology
•
Dermatology
•
Alopecia
What is your approach to diagnosing and managing methotrexate-induced alopecia?
What are the typical clinical patterns you observe?
Related Questions
Do you always get a baseline chest xray in patients who will be starting methotrexate?
What is your approach to methotrexate use (or avoidance) in patients with varying MTHFR mutations?
Can Xolair (omalizumab) be safely used in combination with biologics for patients with rheumatic disease?
Can Dupixent (dupliumab) be safely used in patients who are taking other biologics for rheumatic disease?
What is your approach to differentiating RA-ILD from medication toxicity (I.e. from methotrexate)?
How would you manage a patient with hidradenitis suppurativa and inflammatory arthritis (RA vs. PsA)?
What biologics would you use in a patient with rheumatoid arthritis who developed multiple basal cell carcinomas requiring Mohs surgery while on a TNF-inhibitor and did not respond to rituximab?
What is your treatment approach for a young female who has an idiopathic small right elbow effusion with synovial thickening that has resulted in limitation in her range of motion?
What is your typical steroid taper regimen for managing RA flares?
Is it safe to use one TNF inhibitor (e.g., infliximab) in a patient who has had a severe allergic reaction to a different TNF inhibitor (e.g., adalimumab)?